Supply Chain / Indian Pharma Manufacturing: Back in Business
COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and…
The global rush to secure access to COVID-19 vaccines has led to accusations that richer countries are hoarding supply at the expense of poorer nations. While some are calling for…
COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and…
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…
Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with…
VS Reddy, fondly known as ‘The Protein Man of India’ and founder and managing director of British Biologicals, India’s leading nutraceutical company, provides insights into the pioneering role played by British Biologicals in raising awareness about and fostering the use of nutraceuticals in India, while he documents his plans to leverage the company’s unique brands to swiftly strengthen its international…
The US generics market stood at USD 69 billion in 2018 and is expected to grow to USD 86 billion by 2022. Made…
An insight into biosimilars & biologics in Indian Pharma. Prepared in association with Nishith Desai &…
The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions…
Deloitte predicts that the global market for biosimilars will reach between USD 25 and 35 billion by 2020, driven…
What probably best explains the contrasts in the Indian pharmaceutical landscape is the fact that India can take…
Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming…
Eurasia Group’s Aditya Bhattacharji tackles three more key geopolitical issues that global pharma needs to be…
COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and…
In a context where even well-established, multi-billion-dollar domestic companies have received warning letters…
COVID-19 has highlighted the importance of secure regional pharma supply chains across the globe, not least in…
Below is a selection of the top stories in Indian pharma from recent months, ranging from efforts to counter the…
Indian firm Biocon has seen great success in the US in recent years, with two biosimilar launches and a range of…
Indian pharma production is growing rapidly – boosted by the Modi government’s ‘Make in India’ campaign…
Indian pharma companies provide affordable generic drugs to patients in almost all countries across the globe,…
For multinational companies, despite ‘pharmerging markets’ not holding the hype and allure they once did, India…
The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports…
At the Organization of Pharmaceuticals Producers of India (OPPI), the association representing the research-based…
Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more…
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…
One issue grinding the gears of the Indian pharmaceutical industry over recent years has been quality compliance.…
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with…
The editorial team at Panorama Farmaceutico explain why coordinated action is needed within Brazilian pharma to…
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic…
With the Indian public healthcare apparatus straining at the seams to provide affordable access to treatments to…
“India, as a manufacturing hub, offers safe, effective, quality medicines, at the very best prices. Now, we…
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s…
India could boost its GDP by USD 0.7 trillion in 2025 by matching the rate of improvement of gender equality of the…
The latest from healthcare and the life sciences in Latin America, including the most recent wave of Indian pharma…